September 9, 2024
TOPLINE: The likelihood of receiving a dementia diagnosis in older adults varies significantly by region across the United States, a new study suggests. Rates ranged from […]
September 9, 2024
Adding balloon angioplasty to aggressive medical management significantly lowers the risk for stroke or death in patients with symptomatic intracranial atherosclerotic stenosis (sICAS), results of a […]
September 6, 2024
A potential first-in-class therapy for migraine prevention has shown promise in a phase 2a proof-of-concept study, with a single infusion reducing migraine frequency over 4 weeks. […]
September 6, 2024
Living in areas saturated with artificial outdoor light at night is associated with an increased risk for Alzheimer’s disease (AD), a new national study suggested. Analyses […]
September 5, 2024
TOPLINE: A history of migraine is not associated with an elevated risk for Parkinson’s disease (PD) in women, regardless of headache frequency or migraine subtype, a […]
September 3, 2024
(Reuters) -Athira Pharma said on Tuesday its drug failed to meet the main goal in a mid-to-late stage trial in patients with mild-to-moderate Alzheimer’s disease. The […]
August 28, 2024
If you encourage patients coming back from stroke to exercise, you’re doing the right thing. Regular physical activity can help improve recovery and reduce the risk […]
August 26, 2024
Advocacy groups for patients with neurologic disorders have become a common feature in the landscape of drug and device development and federal research funding allocation. On […]
August 23, 2024
TOPLINE: There is no link between the COVID-19 vaccination and an increased risk for multiple sclerosis (MS) relapse in most patients. However, there is a small […]